Physician profile
Jay M Weiss
NPI 1598858664
$562.10
in general payments reported to CMS, 2019-2025
11 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.55 · 2022: $163 · 2023: $75.97 · 2024: $76.44 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $173.62 | 2022-2025 | Botox |
| Biohaven Pharmaceutical Holding Company LTD. | $107.24 | 2022 | |
| Lilly USA, LLC | $51.48 | 2022-2024 | Emgality |
| Ucb, INC. | $38.06 | 2021 | |
| Neurocrine Biosciences, INC. | $32.49 | 2021 | |
| Axsome Therapeutics, INC. | $30.31 | 2025 | Symbravo |
| Alnylam Pharmaceuticals INC. | $29.12 | 2025 | Amvuttra |
| Tanabe Pharma America, INC. | $26.22 | 2023 | |
| Kyowa Kirin, INC. | $25.93 | 2024 | Nourianz |
| Amneal Pharmaceuticals LLC | $24.79 | 2025 | Crexont |
| Eisai INC. | $22.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.